• Join our community!

    Do you have questions about celiac disease or the gluten-free diet?

  • Ads by Google:
     




    Get email alerts Subscribe to Celiac.com's FREE weekly eNewsletter

    Ads by Google:



       Get email alertsSubscribe to Celiac.com's FREE weekly eNewsletter

  • Member Statistics

    72,027
    Total Members
    3,093
    Most Online
    chrissy-b
    Newest Member
    chrissy-b
    Joined
  • Announcements

    • admin

      Frequently Asked Questions About Celiac Disease   04/07/2018

      This Celiac.com FAQ on celiac disease will guide you to all of the basic information you will need to know about the disease, its diagnosis, testing methods, a gluten-free diet, etc.   Subscribe to Celiac.com's FREE weekly eNewsletter   What are the major symptoms of celiac disease? Celiac Disease Symptoms What testing is available for celiac disease?  Celiac Disease Screening Interpretation of Celiac Disease Blood Test Results Can I be tested even though I am eating gluten free? How long must gluten be taken for the serological tests to be meaningful? The Gluten-Free Diet 101 - A Beginner's Guide to Going Gluten-Free Is celiac inherited? Should my children be tested? Ten Facts About Celiac Disease Genetic Testing Is there a link between celiac and other autoimmune diseases? Celiac Disease Research: Associated Diseases and Disorders Is there a list of gluten foods to avoid? Unsafe Gluten-Free Food List (Unsafe Ingredients) Is there a list of gluten free foods? Safe Gluten-Free Food List (Safe Ingredients) Gluten-Free Alcoholic Beverages Distilled Spirits (Grain Alcohols) and Vinegar: Are they Gluten-Free? Where does gluten hide? Additional Things to Beware of to Maintain a 100% Gluten-Free Diet What if my doctor won't listen to me? An Open Letter to Skeptical Health Care Practitioners Gluten-Free recipes: Gluten-Free Recipes
  • 0

    GENERAL MILLS LOOKS TO PATENT GLUTEN-FREE PASTA MANUFACTURING PROCESS


    Jefferson Adams


    • The processs General Mills hopes to patent delivers an improved process for a commercially manufacturable gluten-free or reduced-gluten pasta


    Celiac.com 12/26/2017 - Because gluten is vital to the texture, structure and stretch of pasta, replicating pasta without gluten is especially difficult. It's even harder for fresh pastas, and harder still for filled pastas, like ravioli and tortellini.


    Ads by Google:




    ARTICLE CONTINUES BELOW ADS
    Ads by Google:



    In the case of pasta, the trick is to get the pasta to stretch around the filling. In traditional fresh pastas, the stretch comes from gluten in the wheat flour.

    General Mills thinks it has found an answer in a cold extrusion process of pasta dough made with a special blend of flours and gums. The company's process allows the successful manufacture of a variety of free-from, fresh pastas including ravioli, tortellini and agnolotti; products that were previously hard to make without gluten.

    The company is looking to patent its new method for manufacturing gluten-free filled pastas, such as ravioli, without any breaking or tearing during production. For this patent, the company chose a blend of rice flour and cornstarch had been chosen for a bland flavor profile, and relies on 2-3% xanthan gum for structure and flexibility. The process works best by including at least 10% fresh egg by by mass.

    The process General Mills hopes to patent delivers an improved process for a commercially manufacturable gluten-free or reduced-gluten pasta.

    Other parts of the General Mills process include: cold extruding the mixture into sheets of around 1-1.2mm thickness at 34 C or less; adding the filling; and shaping the pasta around it prior to cooling and packing. Early trials showed 32 C was best for plain pasta and 25.7 C for filled pasta. In all cases, the extruder pressure had to be 75 Bar or more.

    General Mills said its invention would help address the increased demand for variety in fresh, gluten-free and reduced-gluten products.

    Source: foodnavigator-usa.com


    Image Caption: Photo: CC--Waferboard
    0


    User Feedback

    Recommended Comments

    Guest dappy

    Posted

    General Mills. We should be thanking them most every day just for their cereals. They are a true pioneer in making gluten free a more normalized experience for celiacs and wheat sensitive individuals. I for one applaud them! Several years ago I wrote to them and asked them to consider making my favorite - Cheerios - available to me as a celiac. Happy to say that it did come about.

    Share this comment


    Link to comment
    Share on other sites
    Guest Sita

    Posted

    Everyone I know who cannot tolerate gluten also has problems with xanthan gum. I am always on the lookout for gluten-free products without it.

    Share this comment


    Link to comment
    Share on other sites
    Guest Rick

    Posted

    Will it be certified gluten free? Since they will be offering "reduced gluten" product as well.

    Share this comment


    Link to comment
    Share on other sites
    Guest Laura

    Posted

    This is wonderful news for most people wishing to avoid gluten. However, it might be problematic for those with celiac/leaky bowel syndrome. For "some" of those people egg and gums must be avoided. The gum is a stomach irritant and the egg a gluten cross-reactor. I am proud of GM taking the needed steps to produce gluten-free products. Isn't a pity that the FDA did not require controlled testing prior to the release of the "modern-dwarf wheat" (2009) with its exorbitant gluten content that resulted in misery for many thousands of people. Near Death by Gluten is not an idiom, but a sad truth my life.

    Share this comment


    Link to comment
    Share on other sites
    Guest Jefferson

    Posted

    Will their products be GMO free?

    I'm confused. What does GMO have to do with gluten-free? What does GMO have to do with celiac disease?

    Share this comment


    Link to comment
    Share on other sites


    Your content will need to be approved by a moderator

    Guest
    You are commenting as a guest. If you have an account, please sign in.
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoticons maximum are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • Popular Contributors

  • Ads by Google:

  • Who's Online   9 Members, 2 Anonymous, 756 Guests (See full list)

  • Related Articles

    Jefferson Adams
    Celiac.com 08/17/2016 - Cereal-maker General Mills is looking to patent method and system for manufacturing gluten-free oats.
    The application for patent protection covers numerous mechanical separation processes on a variety of grains, including oat grains and gluten-containing grains, using, among other things, width grading steps, multiple length grading steps, aspirating steps and a potential de-bearding step.
    Federal labeling regulations require products labeled 'gluten-free' to have gluten levels below 20 ppm. The process allow the production of oat grains with gluten levels below 20 parts per million, and optimally at 10 ppm.
    The resulting oats are gluten-free oats and suitable for use in a variety of gluten-free oat food products, including cereal and granola products, according to the patent US 2016/0207048 A1, filed on July 21st 2016.

    Mechanical separation techniques, such as these covered by the patent application, have the potential to be highly efficient and economical. The patent does not mention more expensive optical systems.
    Oats are naturally gluten-free, but, according to the patent, "oats cultivated in North America, Europe and other parts of the world commonly are contaminated by gluten-containing grains such as wheat, barley, rye and triticale."
    Contamination can result from rotating grains on the same crop land, and from harvesting, transporting, storing and merchandising.
    General Mills experienced problems with wheat contamination of gluten-free products last year, when they were forced to recall an estimated 1.8 million boxes of gluten-free Cheerios and Honey Nut Cheerios at its Lodi, Calif., plant. The product was contaminated with gluten. However, the company has maintained that the gluten contamination was due to an employee processing error, not any defect in their grain sorting equipment covered under the patent protection.
    Stay tuned to find out if General Mills receives their patent, and if their process has a significant impact on the quality, availability and cost of gluten-free oats.

    Jefferson Adams
    Celiac.com 05/09/2017 - For years, industry observers, health experts and even food companies have questioned the staying power of gluten-free food.
    With more people than ever embracing gluten-free products and gluten-free diets, including a majority of folks who do not have celiac disease, gluten-free food has never been more popular. There have also never been more gluten-free products hitting store shelves.
    Couple that with the fact that U.S. sales of gluten-free products are projected to exceed $2 billion by 2019, and the market for gluten-free products looks as solid as ever.
    But, do hidden caveats await potential investors, especially on the retail end? Maybe.
    There's a great article over at Fooddive.com about the challenges of succeeding in the gluten-free grocery business especially on the retail end.
    The article interviews a number of major gluten-free retailers, and notes that the higher margins and intense customer loyalty that come with gluten-free products also come with warning signs that may portend a looming downturn.
    Far from being doom-and-gloom, the article includes some interesting insights on the strategies and tactics being used by retailers to bolster their gluten-free sales.
    Read more at Fooddive.com.

    Jefferson Adams
    Celiac.com 10/27/2017 - Cereal maker General Mills has announced that it will no longer label their flagship cereal Cheerios as gluten-free in Canada.
    Has Canada Changed its Gluten-free Standards?
    No, the standard for labeling gluten-free foods in Canada remains same, at up to 20 ppm allowable gluten. Such foods are safe for the vast majority of people with celiac disease, according to both U.S. and Canadian regulatory agencies, the EU, celiac researchers and numerous celiac disease support groups. Health Canada, the agency responsible for setting food safety standards in Canada says that gluten levels below 20 ppm are safe for people with celiac disease. That is also the standard for gluten-free products in the United States and the EU.
    Have Cheerios Changed?
    No, the Gluten-Free Cheerios sold in the U.S. are the same Cheerios that are sold in Canada now, and the same Cheerios that will be sold in Canada after the labeling change. Cheerios routinely test below 20 ppm, and are currently labeled as gluten-free in both the U.S., and Canada. Cheerios has not been the subject of a mandated recall in with the U.S. or in Canada, which indicates that the product remains safe for the vast majority of people with celiac disease. So, Why is Cheerios Changing its Label in Canada?
    It comes down to a technicality over oat testing standards. Canadian labeling laws require manufacturers follow a specific testing requirement for products made with oats, such as Cheerios. Under that Canadian testing requirement, oat products with gluten levels above 5 ppm, but under 20 ppm are considered "Investigative," a status under which the agency "notifies the regulated party of the result." They then "follow up with the regulated party to determine the source of the gluten." Moreover, the agency advises "the regulated party, such as General Mills in the case of Cheerios, to review their Good Manufacturing Practices (GMPs) and process controls." The agency may require "corrective action."
    As a result, cereal maker General Mills has announced that it will no longer label their flagship cereal Cheerios as gluten-free in Canada.
    General Mills stands by its testing process and said Cheerios sold in the U.S. will continue to carry the gluten-free label. A statement by General Mills reads: GM: 
    "Each serving of Cheerios products in Canada are gluten free, as defined by the current regulatory standard of containing less than 20 ppm of gluten. General Mills Canada has made the decision to voluntarily remove the gluten-free label from our Cheerios products in Canada until Health Canada and
    The Canadian Food Inspection Agency (CFIA) publish a consistent testing protocol for products containing oats. At this time the product is not changing, just the label on the box. We look forward to labeling the Cheerios products in Canada as gluten free once consensus is reached on a consistent testing protocol for products containing oats."
    Comments made by both General Mills and the CFIA suggest the decision to remove the gluten-free labels from Cheerios stem from an issue around how products containing oats are tested for gluten in Canada.
    According to CBC News, the Canadian Food Inspection Agency confirmed that the move by General Mills to remove the gluten-free label was voluntary, and said the company had "informed" the agency of its plans in August.
    "This was a business decision made by the company and not a directive from the CFIA," the statement said.
    The statement from GM continues: "While Gluten-Free Cheerios products comply with the gluten-free standards in Canada and the United States, we have made the decision to remove the gluten-free label from our Cheerios products in Canada until the government agencies publish a consistent testing protocol for products containing oats. At this time the product is not changing, just the label on the box.
    For nearly a decade, General Mills has served consumers with Celiac disease and gluten sensitivities. Since Gluten Free Rice Chex was launched in 2008, General Mills has grown its portfolio of gluten-free products to more than 1,000 items. It is now the second largest provider of gluten-free foods, including seven varieties of Cheerios, in the U.S. The company has also introduced gluten-free products in more away-from-home food outlets like restaurants and schools, and in new regions such as Canada and Europe."
    GM spokesperson Mike Siemienas said the company was waiting for "Health Canada and The Canadian Food Inspection Agency (CFIA) [to] publish a consistent testing protocol for products containing oats," and that General Mills looks forward to labeling the Cheerios products as gluten-free once consensus is reached on a consistent testing protocol."
    So, while Cheerios will no longer carry a gluten-free label in Canada, Canadian standards for gluten-free products have not changed, and remain the same as American standards, at up to 20 ppm allowable gluten. The Cheerios sold in Canada are no different than Cheerios sold in the United States, where they will still carry a gluten-free label.
    So, only the Canadian label will change. Cheerios will remain the same. On either side of the border, people with celiac disease can continue to enjoy Cheerios with confidence.
    Those with oat sensitivity, or who react to high fiber levels, should use their own judgement about Cheerios, as with any other product.

    Jefferson Adams
    Celiac.com 12/18/2018 - Evidence compiled by Quaker Oats shows that 4% of the purity protocol oats the company uses to make "gluten-free" oatmeal products are contaminated with trace amounts of gluten. Overall, these batches may contain under 20 ppm gluten, and thus be considered gluten-free. But somehow, isolated kernels of wheat, barley or rye flakes were making their way into the final oatmeal products and onto store shelves.
    Because these kernels were rolled flat the same way as the oats, it was possible for one of these flakes to find its way into a bowl of otherwise gluten-free oats, and to render the bowl over the 20 ppm standard, meaning it is technically not gluten-free, according to FDA standard.
    Quaker found a solution in a stricter testing method. The testing method used by Quaker mirrors the testing method recently adopted by the CFA. Under that method, "oat groats are collected from gluten-free oat production following a robust attribute-based sampling plan then split into 75-g subsamples, and ground. R-Biopharm R5 sandwich ELISA R7001 is used for analysis of all the first 15-g portions of the ground sample.
    A less than 20-ppm result disqualifies the production lot, while a greater than 5 to less than 20-ppm result triggers complete analysis of the remaining 60-g of ground sample, analyzed in 15-g portions.
    If all five 15-g test results are less than 20 ppm, and their average is less than 10.67 ppm (since a 20-ppm contaminant in 40 g of oats would dilute to 10.67 ppm in 75-g), the lot is passed.
    Most oatmeal is made from rolled whole oats. That means that, even with just 4% gluten contamination, products made with whole oats, even rolled oats, can contain pockets of gluten that might render a given serving over the 20 ppm standard. Because Quaker, or their oat supplier, lacks a sorting process for eliminating or reducing gluten-contamination in its raw purity protocol oats, and because its oatmeal is minimally processed, the problem of loose individual flakes of wheat, barley or rye remains unsolved at the manufacturing level. This is true for Quaker in a way that is not true for General Mills.
    No matter how much Quaker mixes rolled oats, a single wayward flake of wheat, rye or barley will remain intact and eventually turn up in a serving portion. That's true, even if it's just an isolated flake. That means that Quaker must look for a solution in its supply chain.
    So, Quaker's approach makes sense for products made with whole oats. However, the challenges faced by Quaker in making gluten-free oatmeal are substantially different than the challenges faced by General Mills in making a product like Cheerios. That's because of differences in the processes used to make the two products.
    Because General Mills uses a process to sort its raw oats to below 20 ppm allowable gluten, and because it then grinds the raw oats into oat flour, there is no danger that intact flakes of wheat, rye or barley will make their way into any given serving. The flour is mixed thoroughly, and, thus, any flour from the wayward oat flake is now blended evenly into the rest of the batch. The oat flour is then mixed further with other ingredients to become the raw material for making Cheerios.
    So, it's extremely unlikely that Cheerios would suffer from the types of gluten "hotspots" that Quaker found in their supposedly gluten-free purity protocol oats. The process greatly increases the likelihood that any gluten would be evenly distributed into the final product, and thus be gluten-free below 20 ppm at the serving level.
    Essentially, the two studies by scientists at Quaker show a couple of things. First, whole oats, and products made with whole oats, even those labeled gluten-free, even those which are harvested as "purity protocol," can contain isolated pockets or "hotspots" of gluten. This may mean that these products can cause symptoms in people with celiac disease. People with celiac disease should be vigilant about these products. Trust your gut and eat accordingly. Second, the data gathered, and the conclusions reached, by the Quaker scientists regarding Quaker's efforts to produce gluten-free oatmeal, have little or no connection to General Mills and the process used to make Cheerios.
    It would be a mistake to project Quaker's challenges onto General Mills. For its part, it seems that General Mills has actually solved the challenges of removing wheat, rye and barley from oats to reach levels below 20 ppm, and to manufacture products that reflect that gluten-free status. General Mills has solved the challenge at the manufacturing level in a way Quaker has not.
    For all its refined testing procedures, Quaker is still reliant on its suppliers to deliver gluten-free oats. Somewhere, somehow the problem of quantifying the gluten content of raw oats and rendering that level to be within gluten-free standards still has to be solved.
    Quaker is relying on oat growers and suppliers to solve the problem, to develop a way to quantify and reduce the gluten contamination levels of raw "purity protocol" oats. Perhaps Quaker might benefit from optical sorting technology, or other processes that allow them to exert more control over their finished product at the manufacturing level?
    Celiac.com is not alone in saying that optically sorted oats likely safe. That view is also held by the Gluten Intolerance Group.
    Read articles on the original studies by scientists at Quaker Oats at Food Chemistry, and the International Journal of Food Science Technology.
    Sources:
    Food Chemistry. Volume 240, 1 February 2018, Pages 391-395 Int J Food Sci Technol, 52: 359–365.  DOI: 10.1111/ijfs.13288 http://onlinelibrary.wiley.com/doi/10.1111/ijfs.13288/full General Mills Describes the Success of its Gluten Detection System

  • Recent Articles

    Connie Sarros
    Celiac.com 04/21/2018 - Dear Friends and Readers,
    I have been writing articles for Scott Adams since the 2002 Summer Issue of the Scott-Free Press. The Scott-Free Press evolved into the Journal of Gluten Sensitivity. I felt honored when Scott asked me ten years ago to contribute to his quarterly journal and it's been a privilege to write articles for his publication ever since.
    Due to personal health reasons and restrictions, I find that I need to retire. My husband and I can no longer travel the country speaking at conferences and to support groups (which we dearly loved to do) nor can I commit to writing more books, articles, or menus. Consequently, I will no longer be contributing articles to the Journal of Gluten Sensitivity. 
    My following books will still be available at Amazon.com:
    Gluten-free Cooking for Dummies Student's Vegetarian Cookbook for Dummies Wheat-free Gluten-free Dessert Cookbook Wheat-free Gluten-free Reduced Calorie Cookbook Wheat-free Gluten-free Cookbook for Kids and Busy Adults (revised version) My first book was published in 1996. My journey since then has been incredible. I have met so many in the celiac community and I feel blessed to be able to call you friends. Many of you have told me that I helped to change your life – let me assure you that your kind words, your phone calls, your thoughtful notes, and your feedback throughout the years have had a vital impact on my life, too. Thank you for all of your support through these years.

    Jefferson Adams
    Celiac.com 04/20/2018 - A digital media company and a label data company are teaming up to help major manufacturers target, reach and convert their desired shoppers based on dietary needs, such as gluten-free diet. The deal could bring synergy in emerging markets such as the gluten-free and allergen-free markets, which represent major growth sectors in the global food industry. 
    Under the deal, personalized digital media company Catalina will be joining forces with Label Insight. Catalina uses consumer purchases data to target shoppers on a personal base, while Label Insight works with major companies like Kellogg, Betty Crocker, and Pepsi to provide insight on food label data to government, retailers, manufacturers and app developers.
    "Brands with very specific product benefits, gluten-free for example, require precise targeting to efficiently reach and convert their desired shoppers,” says Todd Morris, President of Catalina's Go-to-Market organization, adding that “Catalina offers the only purchase-based targeting solution with this capability.” 
    Label Insight’s clients include food and beverage giants such as Unilever, Ben & Jerry's, Lipton and Hellman’s. Label Insight technology has helped the Food and Drug Administration (FDA) build the sector’s very first scientifically accurate database of food ingredients, health attributes and claims.
    Morris says the joint partnership will allow Catalina to “enhance our dataset and further increase our ability to target shoppers who are currently buying - or have shown intent to buy - in these emerging categories,” including gluten-free, allergen-free, and other free-from foods.
    The deal will likely make for easier, more precise targeting of goods to consumers, and thus provide benefits for manufacturers and retailers looking to better serve their retail food customers, especially in specialty areas like gluten-free and allergen-free foods.
    Source:
    fdfworld.com

    Jefferson Adams
    Celiac.com 04/19/2018 - Previous genome and linkage studies indicate the existence of a new disease triggering mechanism that involves amino acid metabolism and nutrient sensing signaling pathways. In an effort to determine if amino acids might play a role in the development of celiac disease, a team of researchers recently set out to investigate if plasma amino acid levels differed among children with celiac disease compared with a control group.
     
    The research team included Åsa Torinsson Naluai, Ladan Saadat Vafa, Audur H. Gudjonsdottir, Henrik Arnell, Lars Browaldh, and Daniel Agardh. They are variously affiliated with the Institute of Biomedicine, Department of Microbiology & Immunology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; the Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; the Department of Pediatric Gastroenterology, Hepatology and Nutrition, Karolinska University Hospital and Division of Pediatrics, CLINTEC, Karolinska Institute, Stockholm, Sweden; the Department of Clinical Science and Education, Karolinska Institute, Sodersjukhuset, Stockholm, Sweden; the Department of Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden; the Diabetes & Celiac Disease Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden; and with the Nathan S Kline Institute in the U.S.A.
    First, the team used liquid chromatography-tandem mass spectrometry (LC/MS) to analyze amino acid levels in fasting plasma samples from 141 children with celiac disease and 129 non-celiac disease controls. They then crafted a general linear model using age and experimental effects as covariates to compare amino acid levels between children with celiac disease and non-celiac control subjects.
    Compared with the control group, seven out of twenty-three children with celiac disease showed elevated levels of the the following amino acids: tryptophan; taurine; glutamic acid; proline; ornithine; alanine; and methionine.
    The significance of the individual amino acids do not survive multiple correction, however, multivariate analyses of the amino acid profile showed significantly altered amino acid levels in children with celiac disease overall and after correction for age, sex and experimental effects.
    This study shows that amino acids can influence inflammation and may play a role in the development of celiac disease.
    Source:
    PLoS One. 2018; 13(3): e0193764. doi: & 10.1371/journal.pone.0193764

    Jefferson Adams
    Celiac.com 04/18/2018 - To the relief of many bewildered passengers and crew, no more comfort turkeys, geese, possums or other questionable pets will be flying on Delta or United without meeting the airlines' strict new requirements for service animals.
    If you’ve flown anywhere lately, you may have seen them. People flying with their designated “emotional support” animals. We’re not talking genuine service animals, like seeing eye dogs, or hearing ear dogs, or even the Belgian Malinois that alerts its owner when there is gluten in food that may trigger her celiac disease.
    Now, to be honest, some of those animals in question do perform a genuine service for those who need emotional support dogs, like veterans with PTSD.
    However, many of these animals are not service animals at all. Many of these animals perform no actual service to their owners, and are nothing more than thinly disguised pets. Many lack proper training, and some have caused serious problems for the airlines and for other passengers.
    Now the major airlines are taking note and introducing stringent requirements for service animals.
    Delta was the first to strike. As reported by the New York Times on January 19: “Effective March 1, Delta, the second largest US airline by passenger traffic, said it will require passengers seeking to fly with pets to present additional documents outlining the passenger’s need for the animal and proof of its training and vaccinations, 48 hours prior to the flight.… This comes in response to what the carrier said was a 150 percent increase in service and support animals — pets, often dogs, that accompany people with disabilities — carried onboard since 2015.… Delta said that it flies some 700 service animals a day. Among them, customers have attempted to fly with comfort turkeys, gliding possums, snakes, spiders, and other unusual pets.”
    Fresh from an unsavory incident with an “emotional support” peacock incident, United Airlines has followed Delta’s lead and set stricter rules for emotional support animals. United’s rules also took effect March 1, 2018.
    So, to the relief of many bewildered passengers and crew, no more comfort turkeys, geese, possums or other questionable pets will be flying on Delta or United without meeting the airlines' strict new requirements for service and emotional support animals.
    Source:
    cnbc.com

    admin
    WHAT IS CELIAC DISEASE?
    Celiac disease is an autoimmune condition that affects around 1% of the population. People with celiac disease suffer an autoimmune reaction when they consume wheat, rye or barley. The immune reaction is triggered by certain proteins in the wheat, rye, or barley, and, left untreated, causes damage to the small, finger-like structures, called villi, that line the gut. The damage occurs as shortening and villous flattening in the lamina propria and crypt regions of the intestines. The damage to these villi then leads to numerous other issues that commonly plague people with untreated celiac disease, including poor nutritional uptake, fatigue, and myriad other problems.
    Celiac disease mostly affects people of Northern European descent, but recent studies show that it also affects large numbers of people in Italy, China, Iran, India, and numerous other places thought to have few or no cases.
    Celiac disease is most often uncovered because people experience symptoms that lead them to get tests for antibodies to gluten. If these tests are positive, then the people usually get biopsy confirmation of their celiac disease. Once they adopt a gluten-free diet, they usually see gut healing, and major improvements in their symptoms. 
    CLASSIC CELIAC DISEASE SYMPTOMS
    Symptoms of celiac disease can range from the classic features, such as diarrhea, upset stomach, bloating, gas, weight loss, and malnutrition, among others.
    LESS OBVIOUS SYMPTOMS
    Celiac disease can often less obvious symptoms, such fatigue, vitamin and nutrient deficiencies, anemia, to name a few. Often, these symptoms are regarded as less obvious because they are not gastrointestinal in nature. You got that right, it is not uncommon for people with celiac disease to have few or no gastrointestinal symptoms. That makes spotting and connecting these seemingly unrelated and unclear celiac symptoms so important.
    NO SYMPTOMS
    Currently, most people diagnosed with celiac disease do not show symptoms, but are diagnosed on the basis of referral for elevated risk factors. 

    CELIAC DISEASE VS. GLUTEN INTOLERANCE
    Gluten intolerance is a generic term for people who have some sort of sensitivity to gluten. These people may or may not have celiac disease. Researchers generally agree that there is a condition called non-celiac gluten sensitivity. That term has largely replaced the term gluten-intolerance. What’s the difference between celiac disease and non-celiac gluten-sensitivity? 
    CELIAC DISEASE VS. NON-CELIAC GLUTEN SENSITIVITY (NCGS)
    Gluten triggers symptoms and immune reactions in people with celiac disease. Gluten can also trigger symptoms in some people with NCGS, but the similarities largely end there.

    There are four main differences between celiac disease and non-celiac gluten sensitivity:
    No Hereditary Link in NCGS
    Researchers know for certain that genetic heredity plays a major role in celiac disease. If a first-degree relative has celiac disease, then you have a statistically higher risk of carrying genetic markers DQ2 and/or DQ8, and of developing celiac disease yourself. NCGS is not known to be hereditary. Some research has shown certain genetic associations, such as some NCGS patients, but there is no proof that NCGS is hereditary. No Connection with Celiac-related Disorders
    Unlike celiac disease, NCGS is so far not associated with malabsorption, nutritional deficiencies, or a higher risk of autoimmune disorders or intestinal malignancies. No Immunological or Serological Markers
    People with celiac disease nearly always test positive for antibodies to gluten proteins. Researchers have, as yet, identified no such antobodies or serologic markers for NCGS. That means that, unlike with celiac disease, there are no telltale screening tests that can point to NCGS. Absence of Celiac Disease or Wheat Allergy
    Doctors diagnose NCGS only by excluding both celiac disease, an IgE-mediated allergy to wheat, and by the noting ongoing adverse symptoms associated with gluten consumption. WHAT ABOUT IRRITABLE BOWEL SYNDROME (IBS) AND IRRITABLE BOWEL DISEASE (IBD)?
    IBS and IBD are usually diagnosed in part by ruling out celiac disease. Many patients with irritable bowel syndrome are sensitive to gluten. Many experience celiac disease-like symptoms in reaction to wheat. However, patients with IBS generally show no gut damage, and do not test positive for antibodies to gliadin and other proteins as do people with celiac disease. Some IBS patients also suffer from NCGS.

    To add more confusion, many cases of IBS are, in fact, celiac disease in disguise.

    That said, people with IBS generally react to more than just wheat. People with NCGS generally react to wheat and not to other things, but that’s not always the case. Doctors generally try to rule out celiac disease before making a diagnosis of IBS or NCGS. 
    Crohn’s Disease and celiac disease share many common symptoms, though causes are different.  In Crohn’s disease, the immune system can cause disruption anywhere along the gastrointestinal tract, and a diagnosis of Crohn’s disease typically requires more diagnostic testing than does a celiac diagnosis.  
    Crohn’s treatment consists of changes to diet and possible surgery.  Up to 10% of Crohn's patients can have both of conditions, which suggests a genetic connection, and researchers continue to examine that connection.
    Is There a Connection Between Celiac Disease, Non-Celiac Gluten Sensitivity and Irritable Bowel Syndrome? Large Number of Irritable Bowel Syndrome Patients Sensitive To Gluten Some IBD Patients also Suffer from Non-Celiac Gluten Sensitivity Many Cases of IBS and Fibromyalgia Actually Celiac Disease in Disguise CELIAC DISEASE DIAGNOSIS
    Diagnosis of celiac disease can be difficult. 

    Perhaps because celiac disease presents clinically in such a variety of ways, proper diagnosis often takes years. A positive serological test for antibodies against tissue transglutaminase is considered a very strong diagnostic indicator, and a duodenal biopsy revealing villous atrophy is still considered by many to be the diagnostic gold standard. 
    But this idea is being questioned; some think the biopsy is unnecessary in the face of clear serological tests and obvious symptoms. Also, researchers are developing accurate and reliable ways to test for celiac disease even when patients are already avoiding wheat. In the past, patients needed to be consuming wheat to get an accurate test result. 
    Celiac disease can have numerous vague, or confusing symptoms that can make diagnosis difficult.  Celiac disease is commonly misdiagnosed by doctors. Read a Personal Story About Celiac Disease Diagnosis from the Founder of Celiac.com Currently, testing and biopsy still form the cornerstone of celiac diagnosis.
    TESTING
    There are several serologic (blood) tests available that screen for celiac disease antibodies, but the most commonly used is called a tTG-IgA test. If blood test results suggest celiac disease, your physician will recommend a biopsy of your small intestine to confirm the diagnosis.
    Testing is fairly simple and involves screening the patients blood for antigliadin (AGA) and endomysium antibodies (EmA), and/or doing a biopsy on the areas of the intestines mentioned above, which is still the standard for a formal diagnosis. Also, it is now possible to test people for celiac disease without making them concume wheat products.

    BIOPSY
    Until recently, biopsy confirmation of a positive gluten antibody test was the gold standard for celiac diagnosis. It still is, but things are changing fairly quickly. Children can now be accurately diagnosed for celiac disease without biopsy. Diagnosis based on level of TGA-IgA 10-fold or more the ULN, a positive result from the EMA tests in a second blood sample, and the presence of at least 1 symptom could avoid risks and costs of endoscopy for more than half the children with celiac disease worldwide.

    WHY A GLUTEN-FREE DIET?
    Currently the only effective, medically approved treatment for celiac disease is a strict gluten-free diet. Following a gluten-free diet relieves symptoms, promotes gut healing, and prevents nearly all celiac-related complications. 
    A gluten-free diet means avoiding all products that contain wheat, rye and barley, or any of their derivatives. This is a difficult task as there are many hidden sources of gluten found in the ingredients of many processed foods. Still, with effort, most people with celiac disease manage to make the transition. The vast majority of celiac disease patients who follow a gluten-free diet see symptom relief and experience gut healing within two years.
    For these reasons, a gluten-free diet remains the only effective, medically proven treatment for celiac disease.
    WHAT ABOUT ENZYMES, VACCINES, ETC.?
    There is currently no enzyme or vaccine that can replace a gluten-free diet for people with celiac disease.
    There are enzyme supplements currently available, such as AN-PEP, Latiglutetenase, GluteGuard, and KumaMax, which may help to mitigate accidental gluten ingestion by celiacs. KumaMax, has been shown to survive the stomach, and to break down gluten in the small intestine. Latiglutenase, formerly known as ALV003, is an enzyme therapy designed to be taken with meals. GluteGuard has been shown to significantly protect celiac patients from the serious symptoms they would normally experience after gluten ingestion. There are other enzymes, including those based on papaya enzymes.

    Additionally, there are many celiac disease drugs, enzymes, and therapies in various stages of development by pharmaceutical companies, including at least one vaccine that has received financial backing. At some point in the not too distant future there will likely be new treatments available for those who seek an alternative to a lifelong gluten-free diet. 

    For now though, there are no products on the market that can take the place of a gluten-free diet. Any enzyme or other treatment for celiac disease is intended to be used in conjunction with a gluten-free diet, not as a replacement.

    ASSOCIATED DISEASES
    The most common disorders associated with celiac disease are thyroid disease and Type 1 Diabetes, however, celiac disease is associated with many other conditions, including but not limited to the following autoimmune conditions:
    Type 1 Diabetes Mellitus: 2.4-16.4% Multiple Sclerosis (MS): 11% Hashimoto’s thyroiditis: 4-6% Autoimmune hepatitis: 6-15% Addison disease: 6% Arthritis: 1.5-7.5% Sjögren’s syndrome: 2-15% Idiopathic dilated cardiomyopathy: 5.7% IgA Nephropathy (Berger’s Disease): 3.6% Other celiac co-morditities include:
    Crohn’s Disease; Inflammatory Bowel Disease Chronic Pancreatitis Down Syndrome Irritable Bowel Syndrome (IBS) Lupus Multiple Sclerosis Primary Biliary Cirrhosis Primary Sclerosing Cholangitis Psoriasis Rheumatoid Arthritis Scleroderma Turner Syndrome Ulcerative Colitis; Inflammatory Bowel Disease Williams Syndrome Cancers:
    Non-Hodgkin lymphoma (intestinal and extra-intestinal, T- and B-cell types) Small intestinal adenocarcinoma Esophageal carcinoma Papillary thyroid cancer Melanoma CELIAC DISEASE REFERENCES:
    Celiac Disease Center, Columbia University
    Gluten Intolerance Group
    National Institutes of Health
    U.S. National Library of Medicine
    Mayo Clinic
    University of Chicago Celiac Disease Center